Literature DB >> 25041328

Treatment strategies to treat antibody-mediated rejection and to reduce donor-specific antibodies.

Stephen D Marks1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25041328     DOI： 10.1111/petr.12284

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN： 1397-3142


× No keyword cloud information.
  3 in total

1.  Plasma-cell-rich infiltrates in paediatric renal transplant biopsies are associated with increased risk of renal allograft failure.

Authors:  Stephanie Dufek; Azaz Khalil; Nizam Mamode; Neil J Sebire; Stephen D Marks
Journal:  Pediatr Nephrol       Date:  2016-10-26       Impact factor: 3.714

2.  Bortezomib may stabilize pediatric renal transplant recipients with antibody-mediated rejection.

Authors:  Meghan H Pearl; Anjali B Nayak; Robert B Ettenger; Dechu Puliyanda; Miguel Fernando Palma Diaz; Qiuheng Zhang; Elaine F Reed; Eileen W Tsai
Journal:  Pediatr Nephrol       Date:  2016-04-05       Impact factor: 3.714

3.  Outcomes of paediatric kidney transplant recipients using the updated 2013/2017 Banff histopathological classification for antibody-mediated rejection.

Authors:  Evgenia Preka; Thivya Sekar; Sergio C Lopez Garcia; Olivia Shaw; Nicos Kessaris; Nizam Mamode; Jelena Stojanovic; Neil J Sebire; Jon Jin Kim; Stephen D Marks
Journal:  Pediatr Nephrol       Date:  2021-06-18       Impact factor: 3.714
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.